Alphabet, Eli Lilly, Dong-A ST and Alexandria Real Estate Equities backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

SoftBank Vision Fund 2 took part in the 401(k) plan provider’s latest round that valued the business at $1bn, six months after it closed a series C.

CapitalG helped data science platform Dataiku raise series E capital, which increased the company's valuation to $4.6bn.

UC Berkeley’s robotics software developer Covariant hiked its overall funding to $147m in a round led by returning investor Index Ventures.

MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

4490 Ventures-backed Rentable has received $22.5m in its series B round.

MIT spinout Quaise has added $12m to its coffers, having previously collected seed funding from The Engine.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

The all-stock transaction is expected to close by the end of this year and will provide an exit to Qualcomm Ventures.

Several corporate investors have backed a series A5 round for the clean nuclear energy technology developer that leverages Oregon State University research.